DRMA · Dermata Therapeutics, Inc.
$1.42
+0.04 (+2.90%)
At close · Aug 21
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$5.71M
Shares
4.02M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-01-07 | New | Biotechnology | $4,124,591 | $4,124,591 | 06b |
| 2025-02-04 | Amendment | Other Technology | $2,550,000 | $2,550,000 | 06b |
| 2025-01-28 | New | Other Technology | $2,550,000 | $2,550,000 | 06b |
| 2024-09-27 | New | Other Technology | $3,498,089 | $3,498,089 | 06b |
| 2023-06-12 | New | Other Technology | Indefinite | $0 | 06b |
Showing 1–5 of 5 filings